COVID-Steroid 2 Trial for Patients

COVID Steroid 2 compares high versus low dose dexamethasone (a steroid) for the treatment of patients with COVID-19.

Dexamethasone has shown promise as a potential treatment for COVID-19. With this trial we aim to see which dose is most effective for critically ill patients.


Trial Sponsor

Professor, MD, Anders Perner
University Hospital Copenhagen, Rigshospitalet
anders.perner@regionh.dk


Useful Documents


Overview of Recruitment